Amneal Pharmaceuticals AMRX
-
-
-
已收盤：-
本益比明細
年季 | 收盤價 | 本業佔比% | 本益比(近四季) | 每股稅後盈餘(元) | 營業利益(千) | 稅後純益(百萬) |
|---|---|---|---|---|---|---|
| 2025Q1 | 8.38 | 106.27 | 0.04 | 100,347 | 12 | |
| 2024Q4 | 7.92 | 163.55 | -0.10 | 75,793 | -31 | |
| 2024Q3 | 8.32 | 109.73 | 0.00 | 88,809 | 0 | |
| 2024Q2 | 6.35 | 110.85 | 0.02 | 95,470 | 6 | |
| 2024Q1 | 6.06 | 109.44 | -0.30 | -10,746 | -92 | |
| 2023Q4 | 6.07 | -59.35 | 180.25 | -0.57 | 14,193 | -99 |
| 2023Q3 | 4.22 | 102.41 | 0.06 | 75,648 | 10 | |
| 2023Q2 | 3.10 | 99.46 | 0.08 | 80,084 | 12 | |
| 2023Q1 | 1.39 | 86.36 | -0.05 | 34,449 | -7 | |
| 2022Q4 | 1.99 | 91.51 | -0.03 | 36,032 | -4 | |
| 2022Q3 | 2.02 | 99.51 | -0.01 | 44,353 | -3 | |
| 2022Q2 | 3.18 | 100.77 | 272.17 | -0.81 | -198,618 | -121 |
| 2022Q1 | 4.17 | 99.53 | 356.51 | -0.01 | 23,305 | -2 |
| 2021Q4 | 4.79 | 63.36 | 67.35 | -0.04 | 11,175 | -6 |
| 2021Q3 | 5.34 | 88.13 | -0.03 | 28,515 | -4 | |
| 2021Q2 | 5.12 | 97.41 | 0.10 | 67,119 | 15 | |
| 2021Q1 | 6.73 | 94.09 | 0.04 | 45,907 | 7 | |
| 2020Q4 | 4.57 | 69.44 | -0.02 | 20,178 | -3 | |
| 2020Q3 | 3.88 | 18.72 | -0.06 | 2,435 | -9 | |
| 2020Q2 | 4.76 | 72.10 | -0.09 | 10,751 | -12 |